Nature of the Event

Hannah Joseph Hospital Limited conducted its 15th Annual General Meeting (AGM) on Wednesday, July 15, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM) in compliance with SEBI Listing Regulations and Companies Act, 2013. The meeting was held from 12:00 Noon IST to 1:02 PM IST.

Key Figures and Dates

  • Final Dividend declared: ₹2 per equity share of face value ₹10 each for financial year ended March 31, 2026
  • Remote e-voting period: July 12, 2026 (9:00 AM IST) to July 14, 2026 (5:00 PM IST) through NSDL
  • AGM date: July 15, 2026 at 12:00 Noon IST
  • Meeting duration: 1 hour 2 minutes
  • Members attendance: 13 members through VC/OAVM

Parties Involved

Directors Present:

  • Dr. Moses Joseph Arunkumar (Chairman & Managing Director)
  • Dr. Fenn Kavitha Fenn Arunkumar (Whole-time Director)
  • Dr. (Ms.) Arunkumar Nalina (Non-Executive Director)
  • Mr. Noyel Arunkumar (Non-Executive Director)
  • Mr. Chinnamanoor Neelakantan Srinivasan (Independent Director)
  • Mr. Ranganathan Mukundan (Independent Director)
  • Mr. Salaivel Pratheep (Independent Director and Chairman of Audit & Stakeholders and Relationship Committee)
  • Mr. Kumarasamy Sureshkumar (Independent Director and Chairman of Nomination and Remuneration Committee)

Key Managerial Personnel Present:

  • CS Yuvaraj Saravanan (Company Secretary & Compliance Officer)
  • Mr. Daniel Dayanand Fenn (Chief Financial Officer)

Auditors Present:

  • CA. A. Padma (M/s. A.V. Subramanian & Co., Chartered Accountants - Statutory Auditors)
  • CA. T. Pandiarajan (M/s. Pandiarajan T & Co., Chartered Accountants - Internal Auditors)
  • CS. S. Rajaguru (M/s. S. Rajaguru & Associates, Practising Company Secretaries - Secretarial Auditor & Scrutinizer)

Business Transacted

Ordinary Business:

1. Adoption of Audited Financial Statements for FY 2025-26 together with Reports of Board of Directors and Statutory Auditors

2. Declaration of Final Dividend of ₹2 per Equity Share of face value ₹10 each for FY 2025-26

3. Re-appointment of Dr. (Ms.) Arunkumar Nalina (DIN: 07495044) as Non-Executive Director, liable to retire by rotation

Additional Information

  • The Statutory Auditors and Secretarial Auditor reports contained no qualifications, reservations, adverse remarks or disclaimers
  • The Chairman highlighted the company's financial and operational performance during FY 2025-26, healthcare industry outlook, and future expansion plans including proposed Oncology Centre and Pharmacy & Laboratory Services
  • Scrutinizer's report and voting results to be submitted to BSE Limited within prescribed timelines
  • Company CIN: L74999TN2011PLC082860

Voting Process

  • Remote e-voting facility provided through National Securities Depository Limited (NSDL)
  • E-voting remained open for 15 minutes after conclusion of meeting for members who hadn't voted remotely
  • M/s. S. Rajaguru & Associates appointed as Scrutinizer for both remote e-voting and e-voting during AGM